NASDAQ

Black Diamond Therapeutics, Inc. (BDTX)

375 Thanks from members

Black Diamond Therapeutics, Inc. (BDTX) displays a mixed market sentiment, balancing strong analyst buy ratings and high price targets with historical share price volatility, sharp drawdowns, and high market beta.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →